p53-induced autophagy and senescence
p53-induced autophagy and senescence |
https://doi.org/10.18632/oncotarget.4170
Xinbing Sui,
Weidong Han,
and Hongming Pan
|
11723-11724 |
The emerging role of CaMKII in cancer
The emerging role of CaMKII in cancer |
https://doi.org/10.18632/oncotarget.3955
Yan-yang Wang,
Ren Zhao,
and Hong Zhe
|
11725-11734 |
Initiation and termination of DNA replication during S phase in relation to cyclins D1, E and A, p21WAF1, Cdt1 and the p12 subunit of DNA polymerase δ revealed in individual cells by cytometry
Initiation and termination of DNA replication during S phase in relation to cyclins D1, E and A, p21WAF1, Cdt1 and the p12 subunit of DNA polymerase δ revealed in individual cells by cytometry |
https://doi.org/10.18632/oncotarget.4149
Zbigniew Darzynkiewicz,
Hong Zhao,
Sufang Zhang,
Marietta Y.W.T. Lee,
Ernest Y.C. Lee,
and Zhongtao Zhang
|
11735-11750 |
Orthogonal targeting of EGFRvIII expressing glioblastomas through simultaneous EGFR and PLK1 inhibition
Orthogonal targeting of EGFRvIII expressing glioblastomas through simultaneous EGFR and PLK1 inhibition |
https://doi.org/10.18632/oncotarget.3996
Ying Shen,
Jie Li,
Masayuki Nitta,
Diahnn Futalan,
Tyler Steed,
Jeffrey M. Treiber,
Zack Taich,
Deanna Stevens,
Jill Wykosky,
Hong-Zhuan Chen,
Bob S. Carter,
Oren J. Becher,
Richard Kennedy,
Fumiko Esashi,
Jann N. Sarkaria,
Frank B. Furnari,
Webster K. Cavenee,
Arshad Desai,
and Clark C. Chen
|
11751-11767 |
HIF-1α and TAZ serve as reciprocal co-activators in human breast cancer cells
HIF-1α and TAZ serve as reciprocal co-activators in human breast cancer cells |
https://doi.org/10.18632/oncotarget.4190
Lisha Xiang,
Daniele M. Gilkes,
Hongxia Hu,
Weibo Luo,
John W. Bullen,
Houjie Liang,
and Gregg L. Semenza
|
11768-11778 |
CSN6 deregulation impairs genome integrity in a COP1-dependent pathway
CSN6 deregulation impairs genome integrity in a COP1-dependent pathway |
https://doi.org/10.18632/oncotarget.3151
Hyun Ho Choi,
Chun-Hui Su,
Lekun Fang,
Jin Zhang,
Sai-Ching J. Yeung,
and Mong-Hong Lee
|
11779-11793 |
ERp19 contributes to tumorigenicity in human gastric cancer by promoting cell growth, migration and invasion
ERp19 contributes to tumorigenicity in human gastric cancer by promoting cell growth, migration and invasion |
https://doi.org/10.18632/oncotarget.3649
Jing Wu,
Xue-hua Chen,
Xin-qiong Wang,
Yi Yu,
Jian-min Ren,
Yuan Xiao,
Tong Zhou,
Pu Li,
and Chun-di Xu
|
11794-11805 |
Fasting induces anti-Warburg effect that increases respiration but reduces ATP-synthesis to promote apoptosis in colon cancer models
Fasting induces anti-Warburg effect that increases respiration but reduces ATP-synthesis to promote apoptosis in colon cancer models |
https://doi.org/10.18632/oncotarget.3688
Giovanna Bianchi,
Roberto Martella,
Silvia Ravera,
Cecilia Marini,
Selene Capitanio,
Annamaria Orengo,
Laura Emionite,
Chiara Lavarello,
Adriana Amaro,
Andrea Petretto,
Ulrich Pfeffer,
Gianmario Sambuceti,
Vito Pistoia,
Lizzia Raffaghello,
and Valter D. Longo
|
11806-11819 |
Fasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibition
Fasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibition |
https://doi.org/10.18632/oncotarget.3689
Irene Caffa,
Vito D’Agostino,
Patrizia Damonte,
Debora Soncini,
Michele Cea,
Fiammetta Monacelli,
Patrizio Odetti,
Alberto Ballestrero,
Alessandro Provenzani,
Valter D. Longo,
and Alessio Nencioni
|
11820-11832 |
AMP-activated protein kinase is dispensable for maintaining ATP levels and for survival following inhibition of glycolysis, but promotes tumour engraftment of Ras-transformed fibroblasts
AMP-activated protein kinase is dispensable for maintaining ATP levels and for survival following inhibition of glycolysis, but promotes tumour engraftment of Ras-transformed fibroblasts |
https://doi.org/10.18632/oncotarget.3738
Joffrey Pelletier,
Danièle Roux,
Benoit Viollet,
Nathalie M. Mazure,
and Jacques Pouysségur
|
11833-11847 |
RAB7 counteracts PI3K-driven macropinocytosis activated at early stages of melanoma development
RAB7 counteracts PI3K-driven macropinocytosis activated at early stages of melanoma development |
https://doi.org/10.18632/oncotarget.4055
Direna Alonso-Curbelo,
Lisa Osterloh,
Estela Cañón,
Tonantzin G. Calvo,
Raúl Martínez-Herranz,
Panagiotis Karras,
Sonia Martínez,
Erica Riveiro-Falkenbach,
Pablo-Ortiz Romero,
José Luis Rodríguez-Peralto,
Joaquín Pastor,
and María S. Soengas
|
11848-11862 |
c-Jun N-terminal kinase 2 prevents luminal cell commitment in normal mammary glands and tumors by inhibiting p53/Notch1 and breast cancer gene 1 expression
c-Jun N-terminal kinase 2 prevents luminal cell commitment in normal mammary glands and tumors by inhibiting p53/Notch1 and breast cancer gene 1 expression |
https://doi.org/10.18632/oncotarget.3787
Michael A. Cantrell,
Nancy D. Ebelt,
Adam D. Pfefferle,
Charles M. Perou,
and Carla Lynn Van Den Berg
|
11863-11881 |
Activation of hypoxia signaling induces phenotypic transformation of glioma cells: implications for bevacizumab antiangiogenic therapy
Activation of hypoxia signaling induces phenotypic transformation of glioma cells: implications for bevacizumab antiangiogenic therapy |
https://doi.org/10.18632/oncotarget.3592
Hui Xu,
Shervin Rahimpour,
Cody L. Nesvick,
Xu Zhang,
Jingyun Ma,
Min Zhang,
Ge Zhang,
Li Wang,
Chunzhang Yang,
Christopher S. Hong,
Anand V. Germanwala,
J. Bradley Elder,
Abhik Ray-Chaudhury,
Yu Yao,
Mark R. Gilbert,
Russell R. Lonser,
John D. Heiss,
Roscoe O. Brady,
Ying Mao,
Jianhua Qin,
and Zhengping Zhuang
|
11882-11893 |
Meta-analysis of organ-specific differences in the structure of the immune infiltrate in major malignancies
Meta-analysis of organ-specific differences in the structure of the immune infiltrate in major malignancies |
https://doi.org/10.18632/oncotarget.4180
Gautier Stoll,
Gabriela Bindea,
Bernhard Mlecnik,
Jérôme Galon,
Laurence Zitvogel,
and Guido Kroemer
|
11894-11909 |
Cripto-1 as a novel therapeutic target for triple negative breast cancer
Cripto-1 as a novel therapeutic target for triple negative breast cancer |
https://doi.org/10.18632/oncotarget.4182
Nadia P. Castro,
Natalie D. Fedorova-Abrams,
Anand S. Merchant,
Maria Cristina Rangel,
Tadahiro Nagaoka,
Hideaki Karasawa,
Malgorzata Klauzinska,
Stephen M. Hewitt,
Kajal Biswas,
Shyam K. Sharan,
and David S. Salomon
|
11910-11929 |
Smad7 protects against chronic aristolochic acid nephropathy in mice
Smad7 protects against chronic aristolochic acid nephropathy in mice |
https://doi.org/10.18632/oncotarget.3718
Xiao-Yu Dai,
Li Zhou,
Xiao-Ru Huang,
Ping Fu,
and Hui-Yao Lan
|
11930-11944 |
Aquaporin 1 and 5 expression decreases during human intervertebral disc degeneration: novel HIF-1-mediated regulation of aquaporins in NP cells
Aquaporin 1 and 5 expression decreases during human intervertebral disc degeneration: novel HIF-1-mediated regulation of aquaporins in NP cells |
https://doi.org/10.18632/oncotarget.3631
Zariel I. Johnson,
Shilpa S. Gogate,
Rebecca Day,
Abbie Binch,
Dessislava Z. Markova,
Neil Chiverton,
Ashley Cole,
Matt Conner,
Irving M. Shapiro,
Christine L. Le Maitre,
and Makarand V. Risbud
|
11945-11958 |
Systemic attenuation of the TGF-β pathway by a single drug simultaneously rejuvenates hippocampal neurogenesis and myogenesis in the same old mammal
Systemic attenuation of the TGF-β pathway by a single drug simultaneously rejuvenates hippocampal neurogenesis and myogenesis in the same old mammal |
https://doi.org/10.18632/oncotarget.3851
Hanadie Yousef,
Michael J. Conboy,
Adam Morgenthaler,
Christina Schlesinger,
Lukasz Bugaj,
Preeti Paliwal,
Christopher Greer,
Irina M. Conboy,
and David Schaffer
|
11959-11978 |
Combined effects of aging and inflammation on renin-angiotensin system mediate mitochondrial dysfunction and phenotypic changes in cardiomyopathies
Combined effects of aging and inflammation on renin-angiotensin system mediate mitochondrial dysfunction and phenotypic changes in cardiomyopathies |
https://doi.org/10.18632/oncotarget.3979
Tyesha N. Burks,
Ruth Marx,
Laura Powell,
Jasma Rucker,
Djahida Bedja,
Elisa Heacock,
Barbara J. Smith,
D. Brian Foster,
David Kass,
Brian O’Rourke,
Jeremy D. Walston,
and Peter M. Abadir
|
11979-11993 |
CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities
CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities |
https://doi.org/10.18632/oncotarget.2740
Stéphane Terry,
Ihsan Y. El-Sayed,
Damien Destouches,
Pascale Maillé,
Nathalie Nicolaiew,
Guillaume Ploussard,
Fannie Semprez,
Cynthia Pimpie,
Himisha Beltran,
Arturo Londono-Vallejo,
Yves Allory,
Alexandre de la Taille,
David S. Salomon,
and Francis Vacherot
|
11994-12008 |
Filamin A phosphorylation by Akt promotes cell migration in response to arsenic
Filamin A phosphorylation by Akt promotes cell migration in response to arsenic |
https://doi.org/10.18632/oncotarget.3617
Lingzhi Li,
Yongju Lu,
Paul M. Stemmer,
and Fei Chen
|
12009-12019 |
Therapeutic targeting of polo-like kinase 1 using RNA-interfering nanoparticles (iNOPs) for the treatment of non-small cell lung cancer
Therapeutic targeting of polo-like kinase 1 using RNA-interfering nanoparticles (iNOPs) for the treatment of non-small cell lung cancer |
https://doi.org/10.18632/oncotarget.2664
Joshua A. McCarroll,
Tanya Dwarte,
Huricha Baigude,
Jason Dang,
Lu Yang,
Rafael B. Erlich,
Kathleen Kimpton,
Joann Teo,
Sharon M. Sagnella,
Mia C. Akerfeldt,
Jie Liu,
Phoebe A. Phillips,
Tariq M. Rana,
and Maria Kavallaris
|
12020-12034 |
Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancer
Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancer |
https://doi.org/10.18632/oncotarget.3574
Friederike Braig,
Manuela März,
Aneta Schieferdecker,
Alexander Schulte,
Mareike Voigt,
Alexander Stein,
Tobias Grob,
Malik Alawi,
Daniela Indenbirken,
Malte Kriegs,
Erik Engel,
Udo Vanhoefer,
Adam Grundhoff,
Sonja Loges,
Kristoffer Riecken,
Boris Fehse,
Carsten Bokemeyer,
and Mascha Binder
|
12035-12047 |
CXCL12-induced VLA-4 activation is impaired in trisomy 12 chronic lymphocytic leukemia cells: a role for CCL21
CXCL12-induced VLA-4 activation is impaired in trisomy 12 chronic lymphocytic leukemia cells: a role for CCL21 |
https://doi.org/10.18632/oncotarget.3660
Sylvia Ganghammer,
Evelyn Hutterer,
Elisabeth Hinterseer,
Gabriele Brachtl,
Daniela Asslaber,
Peter William Krenn,
Tamara Girbl,
Petra Berghammer,
Roland Geisberger,
Alexander Egle,
Antonella Zucchetto,
Anna Kruschinski,
Valter Gattei,
Alexandre Chigaev,
Richard Greil,
and Tanja Nicole Hartmann
|
12048-12060 |
TIMP-1 activated carcinoma-associated fibroblasts inhibit tumor apoptosis by activating SDF1/CXCR4 signaling in hepatocellular carcinoma
TIMP-1 activated carcinoma-associated fibroblasts inhibit tumor apoptosis by activating SDF1/CXCR4 signaling in hepatocellular carcinoma |
https://doi.org/10.18632/oncotarget.3616
Tao Song,
Changwei Dou,
Yuli Jia,
Kangsheng Tu,
and Xin Zheng
|
12061-12079 |
Differential expression of cell cycle regulators in CDK5-dependent medullary thyroid carcinoma tumorigenesis
Differential expression of cell cycle regulators in CDK5-dependent medullary thyroid carcinoma tumorigenesis |
https://doi.org/10.18632/oncotarget.3813
Karine Pozo,
Antje Hillmann,
Alexander Augustyn,
Florian Plattner,
Tao Hai,
Tanvir Singh,
Saleh Ramezani,
Xiankai Sun,
Roswitha Pfragner,
John D. Minna,
Gilbert J. Cote,
Herbert Chen,
James A. Bibb,
and Fiemu E. Nwariaku
|
12080-12093 |
From the core to beyond the margin: a genomic picture of glioblastoma intratumor heterogeneity
From the core to beyond the margin: a genomic picture of glioblastoma intratumor heterogeneity |
https://doi.org/10.18632/oncotarget.3297
Marc Aubry,
Marie de Tayrac,
Amandine Etcheverry,
Anne Clavreul,
Stéphan Saikali,
Philippe Menei,
and Jean Mosser
|
12094-12109 |
Comparison of a healthy miRNome with melanoma patient miRNomes: are microRNAs suitable serum biomarkers for cancer?
Comparison of a healthy miRNome with melanoma patient miRNomes: are microRNAs suitable serum biomarkers for cancer? |
https://doi.org/10.18632/oncotarget.3661
Christiane Margue,
Susanne Reinsbach,
Demetra Philippidou,
Nicolas Beaume,
Casandra Walters,
Jochen G. Schneider,
Dorothée Nashan,
Iris Behrmann,
and Stephanie Kreis
|
12110-12127 |
Discovery of a small molecule targeting SET-PP2A interaction to overcome BCR-ABLT315I mutation of chronic myeloid leukemia
Discovery of a small molecule targeting SET-PP2A interaction to overcome BCR-ABLT315I mutation of chronic myeloid leukemia |
https://doi.org/10.18632/oncotarget.3665
Shuzhen Wang,
Weiquan Xie,
Duowei Wang,
Zhigang Peng,
Yan Zheng,
Nan Liu,
Wen Dai,
Yang Wang,
Zongqiang Wang,
Yong Yang,
and Yijun Chen
|
12128-12140 |
The emerging role of NG2 in pediatric diffuse intrinsic pontine glioma
The emerging role of NG2 in pediatric diffuse intrinsic pontine glioma |
https://doi.org/10.18632/oncotarget.3716
Sridevi Yadavilli,
Joseph Scafidi,
Oren J. Becher,
Amanda M. Saratsis,
Rebecca L. Hiner,
Madhuri Kambhampati,
Santi Mariarita,
Tobey J. MacDonald,
Kari-Elise Codispoti,
Suresh N. Magge,
Jyoti K. Jaiswal,
Roger J. Packer,
and Javad Nazarian
|
12141-12155 |
Tudor staphylococcal nuclease drives chemoresistance of non-small cell lung carcinoma cells by regulating S100A11
Tudor staphylococcal nuclease drives chemoresistance of non-small cell lung carcinoma cells by regulating S100A11 |
https://doi.org/10.18632/oncotarget.3495
Anna Zagryazhskaya,
Olga Surova,
Nadeem S. Akbar,
Giulia Allavena,
Katarina Gyuraszova,
Irina B. Zborovskaya,
Elena M. Tchevkina,
and Boris Zhivotovsky
|
12156-12173 |
Ubiquitin E3 ligase MARCH7 promotes ovarian tumor growth
Ubiquitin E3 ligase MARCH7 promotes ovarian tumor growth |
https://doi.org/10.18632/oncotarget.3650
Jianguo Hu,
Ying Meng,
Tinghe Yu,
Lina Hu,
and Ming Mao
|
12174-12187 |
miR-20b is up-regulated in brain metastases from primary breast cancers
miR-20b is up-regulated in brain metastases from primary breast cancers |
https://doi.org/10.18632/oncotarget.3664
Aamir Ahmad,
Kevin R. Ginnebaugh,
Seema Sethi,
Wei Chen,
Rouba Ali,
Sandeep Mittal,
and Fazlul H. Sarkar
|
12188-12195 |
Hepatitis B virus X protein induces expression of alpha-fetoprotein and activates PI3K/mTOR signaling pathway in liver cells
Hepatitis B virus X protein induces expression of alpha-fetoprotein and activates PI3K/mTOR signaling pathway in liver cells |
https://doi.org/10.18632/oncotarget.2906
Mingyue Zhu,
Junli Guo,
Wei Li,
Yan Lu,
Shigan Fu,
Xieju Xie,
Hua Xia,
Xu Dong,
Yi Chen,
Ming Quan,
Shaojiang Zheng,
Keping Xie,
and Mengsen Li
|
12196-12208 |
FKBPL: a marker of good prognosis in breast cancer
FKBPL: a marker of good prognosis in breast cancer |
https://doi.org/10.18632/oncotarget.3528
Laura Nelson,
Hayley D. McKenn,
Andrea Marshall,
Laoighse Mulrane,
Jane Starczynski,
Sarah J. Storr,
Fiona Lanigan,
Christopher Byrne,
Ken Arthur,
Shauna Hegarty,
Ahlam Abdunnabi Ali,
Fiona Furlong,
Helen McCarthy,
Ian O. Ellis,
Andrew R. Green,
Emad Rakha,
Leonie Young,
Ian Kunkler,
Jeremy Thomas,
Wilma Jack,
David Cameron,
Karin Jirström,
Anita Yakkundi,
Lana McClements,
Stewart G. Martin,
William M. Gallagher,
Janet Dunn,
John Bartlett,
Darran O’Connor,
and Tracy Robson
|
12209-12223 |
Identification of a novel TGF-β-miR-122-fibronectin 1/serum response factor signaling cascade and its implication in hepatic fibrogenesis
Identification of a novel TGF-β-miR-122-fibronectin 1/serum response factor signaling cascade and its implication in hepatic fibrogenesis |
https://doi.org/10.18632/oncotarget.3652
Chunxian Zeng,
Yun-Long Wang,
Chen Xie,
Ye Sang,
Tuan-Jie Li,
Min Zhang,
Ruizhi Wang,
Qi Zhang,
Limin Zheng,
and Shi-Mei Zhuang
|
12224-12233 |
Multi-platform profiling of over 2000 sarcomas: Identification of biomarkers and novel therapeutic targets
Multi-platform profiling of over 2000 sarcomas: Identification of biomarkers and novel therapeutic targets |
https://doi.org/10.18632/oncotarget.3498
Sujana Movva,
Wenhsiang Wen,
Wangjuh Chen,
Sherri Z. Millis,
Zoran Gatalica,
Sandeep Reddy,
Margaret von Mehren,
and Brian A. Van Tine
|
12234-12247 |
Loss of the N-terminal methyltransferase NRMT1 increases sensitivity to DNA damage and promotes mammary oncogenesis
Loss of the N-terminal methyltransferase NRMT1 increases sensitivity to DNA damage and promotes mammary oncogenesis |
https://doi.org/10.18632/oncotarget.3653
Lindsay A. Bonsignore,
Jill Sergesketter Butler,
Carolyn M. Klinge,
and Christine E. Schaner Tooley
|
12248-12263 |
Estrogen receptor (ER) was regulated by RNPC1 stabilizing mRNA in ER positive breast cancer
Estrogen receptor (ER) was regulated by RNPC1 stabilizing mRNA in ER positive breast cancer |
https://doi.org/10.18632/oncotarget.3654
Liang Shi,
Tian-Song Xia,
Xiao-Long Wei,
Wenbin Zhou,
Jinqiu Xue,
Lin Cheng,
Peipei Lou,
Chunlian Li,
Ying Wang,
Ji-Fu Wei,
and Qiang Ding
|
12264-12278 |
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype |
https://doi.org/10.18632/oncotarget.3733
Elisabet Cuyàs,
Salvador Fernández-Arroyo,
Bruna Corominas-Faja,
Esther Rodríguez-Gallego,
Joaquim Bosch-Barrera,
Begoña Martin-Castillo,
Rafael De Llorens,
Jorge Joven,
and Javier A. Menendez
|
12279-12296 |
Molecular stratification of metastatic melanoma using gene expression profiling : Prediction of survival outcome and benefit from molecular targeted therapy
Molecular stratification of metastatic melanoma using gene expression profiling : Prediction of survival outcome and benefit from molecular targeted therapy |
https://doi.org/10.18632/oncotarget.3655
Helena Cirenajwis,
Henrik Ekedahl,
Martin Lauss,
Katja Harbst,
Ana Carneiro,
Jens Enoksson,
Frida Rosengren,
Linda Werner-Hartman,
Therese Törngren,
Anders Kvist,
Erik Fredlund,
Pär-Ola Bendahl,
Karin Jirström,
Lotta Lundgren,
Jillian Howlin,
Åke Borg,
Sofia K. Gruvberger-Saal,
Lao H. Saal,
Kari Nielsen,
Markus Ringnér,
Hensin Tsao,
Håkan Olsson,
Christian Ingvar,
Johan Staaf,
and Göran Jönsson
|
12297-12309 |
Celecoxib increases EGF signaling in colon tumor associated fibroblasts, modulating EGFR expression and degradation
Celecoxib increases EGF signaling in colon tumor associated fibroblasts, modulating EGFR expression and degradation |
https://doi.org/10.18632/oncotarget.3678
Roberta Venè,
Francesca Tosetti,
Simona Minghelli,
Alessandro Poggi,
Nicoletta Ferrari,
and Roberto Benelli
|
12310-12325 |
Infiltrated pre-adipocytes increase prostate cancer metastasis via modulation of the miR-301a/androgen receptor (AR)/TGF-β1/Smad/MMP9 signals
Infiltrated pre-adipocytes increase prostate cancer metastasis via modulation of the miR-301a/androgen receptor (AR)/TGF-β1/Smad/MMP9 signals |
https://doi.org/10.18632/oncotarget.3619
Hongjun Xie,
Lei Li,
Guodong Zhu,
Qiang Dang,
Zhenkun Ma,
Dalin He,
Luke Chang,
Wenbing Song,
Hong-Chiang Chang,
John J. Krolewski,
Kent L. Nastiuk,
Shuyuan Yeh,
and Chawnshang Chang
|
12326-12339 |
Sorafenib and DE605, a novel c-Met inhibitor, synergistically suppress hepatocellular carcinoma
Sorafenib and DE605, a novel c-Met inhibitor, synergistically suppress hepatocellular carcinoma |
https://doi.org/10.18632/oncotarget.3656
Xiufeng Jiang,
Kang Feng,
Ye Zhang,
Zengyao Li,
Fan Zhou,
Huiqiang Dou,
and Tong Wang
|
12340-12356 |
PAQR3 expression is downregulated in human breast cancers and correlated with HER2 expression
PAQR3 expression is downregulated in human breast cancers and correlated with HER2 expression |
https://doi.org/10.18632/oncotarget.3657
Zhenghu Li,
Zhi-Qiang Ling,
Weiwei Guo,
Xiao-Xiao Lu,
Yi Pan,
Zhenzhen Wang,
and Yan Chen
|
12357-12368 |
Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer
Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer |
https://doi.org/10.18632/oncotarget.3682
Inès Dufait,
Julia Katharina Schwarze,
Therese Liechtenstein,
Wim Leonard,
Heng Jiang,
David Escors,
Mark De Ridder,
and Karine Breckpot
|
12369-12382 |
Loss of Wave1 gene defines a subtype of lethal prostate cancer
Loss of Wave1 gene defines a subtype of lethal prostate cancer |
https://doi.org/10.18632/oncotarget.3564
Adam G. Sowalsky,
Rebecca Sager,
Rachel J. Schaefer,
Gennady Bratslavsky,
Pier Paolo Pandolfi,
Steven P. Balk,
and Leszek Kotula
|
12383-12391 |
TOPK is highly expressed in circulating tumor cells, enabling metastasis of prostate cancer
TOPK is highly expressed in circulating tumor cells, enabling metastasis of prostate cancer |
https://doi.org/10.18632/oncotarget.3630
Huimin Sun,
Lei Zhang,
Changhong Shi,
Peizhen Hu,
Wei Yan,
Zhe Wang,
Qiuhong Duan,
Fan Lu,
Lipeng Qin,
Tao Lu,
Juanjuan Xiao,
Yingmei Wang,
Feng Zhu,
and Chen Shao
|
12392-12404 |
NHE9 induces chemoradiotherapy resistance in esophageal squamous cell carcinoma by upregulating the Src/Akt/β-catenin pathway and Bcl-2 expression
NHE9 induces chemoradiotherapy resistance in esophageal squamous cell carcinoma by upregulating the Src/Akt/β-catenin pathway and Bcl-2 expression |
https://doi.org/10.18632/oncotarget.3618
Junying Chen,
Hong Yang,
Jing Wen,
Kongjia Luo,
Qianwen Liu,
Yijie Huang,
Yuzhen Zheng,
Zihui Tan,
Qinyuan Huag,
and Jianhua Fu
|
12405-12420 |
SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiation
SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiation |
https://doi.org/10.18632/oncotarget.3043
Nadia Casini,
Iris Maria Forte,
Gianmarco Mastrogiovanni,
Francesca Pentimalli,
Adriano Angelucci,
Claudio Festuccia,
Valentina Tomei,
Elisa Ceccherini,
Domenico Di Marzo,
Silvia Schenone,
Maurizio Botta,
Antonio Giordano,
and Paola Indovina
|
12421-12435 |
Photochemical activation of MH3-B1/rGel: a HER2-targeted treatment approach for ovarian cancer
Photochemical activation of MH3-B1/rGel: a HER2-targeted treatment approach for ovarian cancer |
https://doi.org/10.18632/oncotarget.3814
Bente Bull-Hansen,
Maria B. Berstad,
Kristian Berg,
Yu Cao,
Ellen Skarpen,
Ane Sofie Fremstedal,
Michael G. Rosenblum,
Qian Peng,
and Anette Weyergang
|
12436-12451 |
SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy
SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy |
https://doi.org/10.18632/oncotarget.3611
Marta Mellai,
Monica Cattaneo,
Alessandra Maria Storaci,
Laura Annovazzi,
Paola Cassoni,
Antonio Melcarne,
Pasquale De Blasio,
Davide Schiffer,
and Ida Biunno
|
12452-12467 |
Targeting the inhibitory receptor CTLA-4 on T cells increased abscopal effects in murine mesothelioma model
Targeting the inhibitory receptor CTLA-4 on T cells increased abscopal effects in murine mesothelioma model |
https://doi.org/10.18632/oncotarget.3487
Licun Wu,
Matthew Onn Wu,
Luis De la Maza,
Zhihong Yun,
Julie Yu,
Yidan Zhao,
John Cho,
and Marc de Perrot
|
12468-12480 |
Induction of c-Cbl contributes to anti-cancer effects of HDAC inhibitor in lung cancer
Induction of c-Cbl contributes to anti-cancer effects of HDAC inhibitor in lung cancer |
https://doi.org/10.18632/oncotarget.3489
Tzu-Tang Wei,
Yu-Chin Lin,
Pei-Hua Lin,
Jin-Yuan Shih,
Chia-Wei Chou,
Wei-Jan Huang,
Yu-Chih Yang,
Pei-Wen Hsiao,
and Ching-Chow Chen
|
12481-12492 |
Combining TGF-β1 knockdown and miR200c administration to optimize antitumor efficacy of B16F10/GPI-IL-21 vaccine
Combining TGF-β1 knockdown and miR200c administration to optimize antitumor efficacy of B16F10/GPI-IL-21 vaccine |
https://doi.org/10.18632/oncotarget.3722
Xiaoying Wang,
Fengshu Zhao,
Xiangfeng He,
Jing Wang,
Ying Zhang,
Hongyi Zhang,
Yaoyao Ni,
Jianan Sun,
Xiaobing Wang,
and Jun Dou
|
12493-12504 |
Inhibition of mutant IDH1 decreases D-2-HG levels without affecting tumorigenic properties of chondrosarcoma cell lines
Inhibition of mutant IDH1 decreases D-2-HG levels without affecting tumorigenic properties of chondrosarcoma cell lines |
https://doi.org/10.18632/oncotarget.3723
Johnny Suijker,
Jan Oosting,
Annemarie Koornneef,
Eduard A. Struys,
Gajja S. Salomons,
Frank G. Schaap,
Cathelijn J.F. Waaijer,
Pauline M. Wijers-Koster,
Inge H. Briaire-de Bruijn,
Lizette Haazen,
Scott M. Riester,
Amel Dudakovic,
Erik Danen,
Anne-Marie Cleton-Jansen,
Andre J. van Wijnen,
and Judith V.M.G. Bovée
|
12505-12519 |
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment |
https://doi.org/10.18632/oncotarget.3724
Michele Iuliani,
Francesco Pantano,
Consuelo Buttigliero,
Marco Fioramonti,
Valentina Bertaglia,
Bruno Vincenzi,
Alice Zoccoli,
Giulia Ribelli,
Marcello Tucci,
Francesca Vignani,
Alfredo Berruti,
Giorgio Vittorio Scagliotti,
Giuseppe Tonini,
and Daniele Santini
|
12520-12528 |
Elevated O-GlcNAcylation promotes colonic inflammation and tumorigenesis by modulating NF-κB signaling
Elevated O-GlcNAcylation promotes colonic inflammation and tumorigenesis by modulating NF-κB signaling |
https://doi.org/10.18632/oncotarget.3725
Yong Ryoul Yang,
Dae Hyun Kim,
Young-Kyo Seo,
Dohyun Park,
Hyun-Jun Jang,
Soo Youn Choi,
Yong Hwa Lee,
Gyun Hui Lee,
Kazuki Nakajima,
Naoyuki Taniguchi,
Jung-Min Kim,
Eun-Jeong Choi,
Hyo Youl Moon,
Il Shin Kim,
Jang Hyun Choi,
Ho Lee,
Sung Ho Ryu,
Lucio Cocco,
and Pann-Ghill Suh
|
12529-12542 |
miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1
miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1 |
https://doi.org/10.18632/oncotarget.3815
Henriett Butz,
Peter M. Szabó,
Heba W.Z. Khella,
Roy Nofech-Mozes,
Attila Patocs,
and George M. Yousef
|
12543-12557 |
Tumor suppressive microRNA-137 negatively regulates Musashi-1 and colorectal cancer progression
Tumor suppressive microRNA-137 negatively regulates Musashi-1 and colorectal cancer progression |
https://doi.org/10.18632/oncotarget.3726
Amber R. Smith,
Rebecca T. Marquez,
Wei-chung Tsao,
Surajit Pathak,
Alexandria Roy,
Jie Ping,
Bailey Wilkerson,
Lan Lan,
Wenjian Meng,
Kristi L. Neufeld,
Xiao-Feng Sun,
and Liang Xu
|
12558-12573 |
5-Fluorouracil sensitizes colorectal tumor cells towards double stranded DNA breaks by interfering with homologous recombination repair
5-Fluorouracil sensitizes colorectal tumor cells towards double stranded DNA breaks by interfering with homologous recombination repair |
https://doi.org/10.18632/oncotarget.3728
Upadhyayula Sai Srinivas,
Jerzy Dyczkowski,
Tim Beißbarth,
Jochen Gaedcke,
Wael Y. Mansour,
Kerstin Borgmann,
and Matthias Dobbelstein
|
12574-12586 |
Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer
Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer |
https://doi.org/10.18632/oncotarget.3494
Stefan J. Barfeld,
Ladan Fazli,
Margareta Persson,
Lisette Marjavaara,
Alfonso Urbanucci,
Kirsi M. Kaukoniemi,
Paul S. Rennie,
Yvonne Ceder,
Andrei Chabes,
Tapio Visakorpi,
and Ian G. Mills
|
12587-12602 |
Quercetin-induced apoptosis prevents EBV infection
Quercetin-induced apoptosis prevents EBV infection |
https://doi.org/10.18632/oncotarget.3687
Minjung Lee,
Myoungki Son,
Eunhyun Ryu,
Yu Su Shin,
Jong Gwang Kim,
Byung Woog Kang,
Hyosun Cho,
and Hyojeung Kang
|
12603-12624 |
MAP17 (PDZKIP1) as a novel prognostic biomarker for laryngeal cancer
MAP17 (PDZKIP1) as a novel prognostic biomarker for laryngeal cancer |
https://doi.org/10.18632/oncotarget.3470
María-José de Miguel-Luken,
Manuel Chaves-Conde,
Verónica de Miguel-Luken,
Sandra Muñoz-Galván,
José Luis López-Guerra,
Juan C. Mateos,
Jerónimo Pachón,
David Chinchón,
Vladimir Suarez,
and Amancio Carnero
|
12625-12636 |
A STAT3-NFkB/DDIT3/CEBPβ axis modulates ALDH1A3 expression in chemoresistant cell subpopulations
A STAT3-NFkB/DDIT3/CEBPβ axis modulates ALDH1A3 expression in chemoresistant cell subpopulations |
https://doi.org/10.18632/oncotarget.3703
Claudia Canino,
YuYing Luo,
Paola Marcato,
Giovanni Blandino,
Harvey I. Pass,
and Mario Cioce
|
12637-12653 |
High USP22 expression indicates poor prognosis in hepatocellular carcinoma
High USP22 expression indicates poor prognosis in hepatocellular carcinoma |
https://doi.org/10.18632/oncotarget.3705
Bo Tang,
Fang Tang,
Bo Li,
Shengguang Yuan,
Qing Xu,
Stephen Tomlinson,
Junfei Jin,
Wei Hu,
and Songqing He
|
12654-12667 |
Maritoclax and dinaciclib inhibit MCL-1 activity and induce apoptosis in both a MCL-1-dependent and -independent manner
Maritoclax and dinaciclib inhibit MCL-1 activity and induce apoptosis in both a MCL-1-dependent and -independent manner |
https://doi.org/10.18632/oncotarget.3706
Shankar Varadarajan,
Paramasivan Poornima,
Mateus Milani,
Krishne Gowda,
Shantu Amin,
Hong-Gang Wang,
and Gerald M. Cohen
|
12668-12681 |
Organ-specific adaptive signaling pathway activation in metastatic breast cancer cells
Organ-specific adaptive signaling pathway activation in metastatic breast cancer cells |
https://doi.org/10.18632/oncotarget.3707
Riesa M. Burnett,
Kelly E. Craven,
Purna Krishnamurthy,
Chirayu P. Goswami,
Sunil Badve,
Peter Crooks,
William P. Mathews,
Poornima Bhat-Nakshatri,
and Harikrishna Nakshatri
|
12682-12696 |
FBXW7 and USP7 regulate CCDC6 turnover during the cell cycle and affect cancer drugs susceptibility in NSCLC
FBXW7 and USP7 regulate CCDC6 turnover during the cell cycle and affect cancer drugs susceptibility in NSCLC |
https://doi.org/10.18632/oncotarget.3708
Francesco Morra,
Chiara Luise,
Francesco Merolla,
Ina Poser,
Roberta Visconti,
Gennaro Ilardi,
Simona Paladino,
Hiroyuki Inuzuka,
Gianluca Guggino,
Roberto Monaco,
David Colecchia,
Guglielmo Monaco,
Aniello Cerrato,
Mario Chiariello,
Krista Denning,
Pier Paolo Claudio,
Stefania Staibano,
and Angela Celetti
|
12697-12709 |
Genomic analysis of xCT-mediated regulatory network: identification of novel targets against AIDS-associated lymphoma
Genomic analysis of xCT-mediated regulatory network: identification of novel targets against AIDS-associated lymphoma |
https://doi.org/10.18632/oncotarget.3710
Lu Dai,
Yueyu Cao,
Yihan Chen,
Johnan A.R. Kaleeba,
Jovanny Zabaleta,
and Zhiqiang Qin
|
12710-12722 |
JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells
JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells |
https://doi.org/10.18632/oncotarget.3713
Bo Tang,
Guangying Qi,
Fang Tang,
Shengguang Yuan,
Zhenran Wang,
Xingsi Liang,
Bo Li,
Shuiping Yu,
Jie Liu,
Qi Huang,
Yangchao Wei,
Run Zhai,
Biao Lei,
Hongping Yu,
Xingyuan Jiao,
and Songqing He
|
12723-12739 |
A standardized autopsy procurement allows for the comprehensive study of DIPG biology
A standardized autopsy procurement allows for the comprehensive study of DIPG biology |
https://doi.org/10.18632/oncotarget.3374
Madhuri Kambhampati,
Jennifer P. Perez,
Sridevi Yadavilli,
Amanda M. Saratsis,
Ashley D. Hill,
Cheng-Ying Ho,
Eshini Panditharatna,
Melissa Markel,
Roger J. Packer,
and Javad Nazarian
|
12740-12747 |
Metformin potentiates rapamycin and cisplatin in gastric cancer in mice
Metformin potentiates rapamycin and cisplatin in gastric cancer in mice |
https://doi.org/10.18632/oncotarget.3327
Guanzhen Yu,
Wenzhang Fang,
Tian Xia,
Ying Chen,
Yunshu Gao,
Xiaodong Jiao,
Suyun Huang,
Zhaosheng Li,
Jiejun Wang,
and Keping Xie
|
12748-12762 |
The prognostic value of the stem-like group in colorectal cancer using a panel of immunohistochemistry markers
The prognostic value of the stem-like group in colorectal cancer using a panel of immunohistochemistry markers |
https://doi.org/10.18632/oncotarget.3497
Chee Wee Ong,
Pei Yi Chong,
Darragh G. McArt,
Jason Yongsheng Chan,
Hwee Tong Tan,
Alan Prem Kumar,
Maxey C. M. Chung,
Marie-Véronique Clément,
Richie Soong,
Sandra Van Schaeybroeck,
David J. J. Waugh,
Patrick G. Johnston,
Philip D. Dunne,
and Manuel Salto-Tellez
|
12763-12773 |
Differences in breast cancer characteristics and outcomes between Caucasian and Chinese women in the US
Differences in breast cancer characteristics and outcomes between Caucasian and Chinese women in the US |
https://doi.org/10.18632/oncotarget.3666
Dan-Na Chen,
Chuan-Gui Song,
Qian-Wen Ouyang,
Yi-Zhou Jiang,
Fu-Gui Ye,
Fang-Jing Ma,
Rong-Cheng Luo,
and Zhi-Ming Shao
|
12774-12782 |
Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma
Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma |
https://doi.org/10.18632/oncotarget.3727
Emilio Bria,
Sara Pilotto,
Eliana Amato,
Matteo Fassan,
Silvia Novello,
Umberto Peretti,
Tiziana Vavalà,
Stefania Kinspergher,
Luisella Righi,
Antonio Santo,
Matteo Brunelli,
Vincenzo Corbo,
Eliana Giglioli,
Isabella Sperduti,
Michele Milella,
Marco Chilosi,
Aldo Scarpa,
and Giampaolo Tortora
|
12783-12795 |
Dual targeting of HER1/EGFR and HER2 with cetuximab and trastuzumab in patients with metastatic pancreatic cancer after gemcitabine failure: results of the “THERAPY”phase 1-2 trial
Dual targeting of HER1/EGFR and HER2 with cetuximab and trastuzumab in patients with metastatic pancreatic cancer after gemcitabine failure: results of the “THERAPY”phase 1-2 trial |
https://doi.org/10.18632/oncotarget.3473
Eric Assenat,
David Azria,
Caroline Mollevi,
Rosine Guimbaud,
Nicole Tubiana-Mathieu,
Denis Smith,
Jean-Pierre Delord,
Emmanuelle Samalin,
Fabienne Portales,
Christel Larbouret,
Bruno Robert,
Frédéric Bibeau,
Jean-Pierre Bleuse,
Evelyne Crapez,
Marc Ychou,
and André Pèlegrin
|
12796-12808 |
Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies
Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies |
https://doi.org/10.18632/oncotarget.3373
Filip Janku,
Philipp Angenendt,
Apostolia M. Tsimberidou,
Siqing Fu,
Aung Naing,
Gerald S. Falchook,
David S. Hong,
Veronica R. Holley,
Goran Cabrilo,
Jennifer J. Wheler,
Sarina A. Piha-Paul,
Ralph G. Zinner,
Agop Y. Bedikian,
Michael J. Overman,
Bryan K. Kee,
Kevin B. Kim,
Scott E. Kopetz,
Rajyalakshmi Luthra,
Frank Diehl,
Funda Meric-Bernstam,
and Razelle Kurzrock
|
12809-12821 |
HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy
HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy |
https://doi.org/10.18632/oncotarget.3431
Cristina Villares Zabalza,
Meike Adam,
Christoph Burdelski,
Waldemar Wilczak,
Corina Wittmer,
Stefan Kraft,
Till Krech,
Stefan Steurer,
Christina Koop,
Claudia Hube-Magg,
Markus Graefen,
Hans Heinzer,
Sarah Minner,
Ronald Simon,
Guido Sauter,
Thorsten Schlomm,
and Maria Christina Tsourlakis
|
12822-12834 |